Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9572828
Treatment for melanoma
granted -
US 9565857
Antimicrobial solutions
granted -
US 9568473
Methods for detecting Ehrlichia infection
granted -
US 9566320
Mucin-associated surface protein as vaccine against Chagas disease
granted -
US 9566251
Volatile anesthetic compositions and methods of use
granted -
US 9562070
Induction of tumor immunity by variants of folate binding protein
granted -
US 9562002
STAT3 inhibitor
granted -
US 9562100
Molecules with extended half-lives, compositions and uses thereof
granted -
US 9561245
Combination treatments for melanoma
granted -
US 9555135
Cobalt-based MRI contrast agent and imaging system
granted -
US 9551721
Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
granted -
US 9551713
Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
granted -
US 9549995
Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy
granted -
US 9539341
Methods and compositions for targeting adipose cells in mammals
granted -
US 9539256
Modulators of exchange proteins directly activated by cAMP (EPACS)
granted -
US 9539283
Citrate-rich calcium-magnesium supplement and uses thereof
granted -
US 9533025
Method for treating chemotherapy-induced male infertility
granted -
US 9527917
Nucleic acid encoding anti-OX40 antibodies
granted -
US 9529005
Modulating bacterial MAM polypeptides in pathogenic disease
granted -
US 9526824
Nanochanneled device and related methods
granted -
US 9522241
Controlled release nanoparticulate matter delivery system
granted -
US 9523079
Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
granted -
US 9517270
Lipocationic polymers and uses thereof
granted -
US 9512401
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy
granted